Results 41 to 50 of about 12,136 (324)
Clinical implications of sugammadex [PDF]
Anaesthesia, 2009 SummarySugammadex is a cyclodextrin molecule that encapsulates and inactivates rocuronium and vecuronium. As a result, any degree of neuromuscular block produced by rocuronium or vecuronium can be rapidly and completely reversed without autonomic effects.
R. D. Miller, J. E. Caldwell
openaire +2 more sources
The use of sugammadex in obese patients [PDF]
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2011 To the Editor, We read with great interest the paper by Le Corre et al. on recurarization after reversal of rocuronium-induced neuromuscular block (NMB) with sugammadex. The authors reported a case of respiratory failure in an obese patient requiring sedation and tracheal intubation in the postoperative period.
CARRON, MICHELE, Parotto E, ORI, CARLO
openaire +4 more sources
Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial [PDF]
, 2015 BACKGROUND: Pipecuronium is a steroidal neuromuscular blocking agent. Sugammadex, a relaxant binding [gamma]-cyclodextrin derivative, reverses the effect of rocuronium, vecuronium, and pancuronium.
Asztalos, László +5 more
core +1 more source
BMC Anesthesiology, 2023 Background Sugammadex is a newer medication used for rapid and reliable reversal of neuromuscular blockade. This study evaluated whether sugammadex could reduce the length of postoperative hospital stay in patients undergoing abdominal surgery.
Jing Tan +6 more
semanticscholar +1 more source
Rocuronium vs Succinylcholine: Emergency Airway Management of the COVID-19 Patient [PDF]
, 2021 Tracheal Intubation is routinely performed in many settings. Anesthesia providers are experts in this procedure. Determination for the best possible approach for tracheal intubation include patient and provider specific considerations. ...
Fowler, Katherine +5 more
core +2 more sources
Sugammadex and rocuronium-induced anaphylaxis [PDF]
Journal of Anesthesia, 2015 Perioperative anaphylaxis is a life-threatening clinical condition that is typically the result of drugs or substances used for anesthesia or surgery. The most common cause of anaphylaxis during anesthesia is reportedly neuromuscular blocking agents.
Tomonori Takazawa +2 more
openalex +5 more sources
Anafilaxia por sugammadex en paciente pediátrico
Revista Alergia México, 2021 Introducción: Sugammadex es una ciclodextrina que revierte el bloqueo neuromuscular, especialmente de rocuronio. La incidencia de anafilaxia producida por su uso es de 1:1.000 y 1:20.000, se observa principalmente en sujetos de origen asiático ...
Juana Bautista Joyanes-Romo +10 more
doaj +1 more source
Neuronal effects of Sugammadex in combination with Rocuronium or Vecuronium. [PDF]
, 2017 Rocuronium (ROC) and Vecuronium (VEC) are the most currently used steroidal non-depolarizing neuromuscular blocking (MNB) agents. Sugammadex (SUG) rapidly reverses steroidal NMB agents after anaesthesia.
Aldasoro Celaya, Martín +10 more
core +1 more source
Bioengineering, 2023 Enhanced Recovery After Surgery (ERAS), an all-encompassing perioperative care approach, has been demonstrated to enhance surgical results, mitigate postoperative issues, and decrease the length of hospital stay (LOS) in diverse surgical specialties.
E. Wu +7 more
semanticscholar +1 more source
Journal of the Formosan Medical Association, 2022 Sugammadex is a direct reversal agent of aminosteroid muscle relaxants, particularly rocuronium, with promptly and completely reverse of deep neuromuscular block (NMB), which allows better surgical conditions. Sugammadex exhibits advantages over indirect
Hsiao-Cheng Chang +4 more
doaj